Dr. Reddy’s, U.K. Firm Join For Self-Injectable Drug Sales
This article was originally published in PharmAsia News
Executive Summary
Dr. Reddy's Laboratories of India has signed a contract with U.K.-based The Medical House to develop, license and supply drugs from India. The Medical House, a drug-delivery specialist, owns an auto injector device technology, which is to be customized and combined with an unnamed Dr. Reddy's drug to create a self-injectable product to reach the market within the next two years. The pact covers the United States, European and Canadian markets, but gives Dr. Reddy's an option to extend it to the rest of the world after the initial five years. (Click here for more